Top-News
  • Watchlist
  • Glocke

  • CAC 40 Index

    7.554,08 -0,05% -3,8624
    20.06.25 22:05:21 Ariva Indikation aktualisieren | Orderbuch | Mehr Kurse »
    WKN: 969400
    ISIN: FR0003500008
    Typ: Index

    Weiter abwärts? Short handeln - Jetzt mit Hebel 5,05: MG2QTS
    Werbung

    Ad-hocs

    20.06.25 - GlobeNewswire
    ArcelorMittal announces sale of Bosnian operations
    20 June 2025, 15:30 CET
    20.06.25 - GlobeNewswire
    Press Release: Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoid
    Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoid
    18.06.25 - GlobeNewswire
    ArcelorMittal completes the acquisition of Nippon Steel Corporation’s interest in AM/NS Calvert
    18 June 2025, 19:30 CET
    18.06.25 - EQS
    EQS-Adhoc: Airbus to present new dividend policy and reaffirm cash conversion target during business update on 18 June 2025
    EQS-​Ad-hoc: Airbus SE / Key word(s): Forecast Airbus to present new dividend policy and reaffirm cash conversion target during business update on 18 June 2025 18-Jun-2025 / ...
    17.06.25 - GlobeNewswire
    Press release: Sanofi successfully prices €1.5 billion bond issue
    Sanofi successfully prices €1.5 billion bond issue
    15.06.25 - GlobeNewswire
    Press Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study
    EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-​ever presented phase 4 ...
    09.06.25 - GlobeNewswire
    Press Release: Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season
    Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season Paris, June 9, 2025. Sanofi is shipping Beyfortus ...
    05.06.25 - GlobeNewswire
    Press release: Sanofi Launches 2025 Global Employee Stock Purchase Plan
    Sanofi Launches 2025 Global Employee Stock Purchase Plan
    03.06.25 - GlobeNewswire
    Press Release: ASCO: new Sarclisa data support subcutaneous administration with on-body injector
    ASCO: new Sarclisa data support subcutaneous administration with on-body injector
    03.06.25 - GlobeNewswire
    Press Release: Rilzabrutinib granted orphan drug designation in the US for sickle cell disease
    Rilzabrutinib granted orphan drug designation in the US for sickle cell disease Fourth orphan drug designation for rilzabrutinib in rare diseases Under regulatory review in the US, ...
    30.05.25 - GlobeNewswire
    Press Release: Itepekimab met the primary endpoint in one of two COPD phase 3 studies
    Itepekimab met the primary endpoint in one of two COPD phase 3 studies AERIFY-1 study met its primary endpoint of a statistically significant reduction in moderate or severe ...
    29.05.25 - GlobeNewswire
    Press Release: Beyfortus public health advantage bolstered by first real-world comparison of infant vs maternal RSV immunization programs
    Beyfortus public health advantage bolstered by first real-​world comparison of infant vs maternal RSV immunization programs Late-​breaking data show infant respiratory syncytial ...
    27.05.25 - GlobeNewswire
    Press Release: Sanofi completes acquisition of DR-0201
    Sanofi completes acquisition of DR-0201
    22.05.25 - GlobeNewswire
    Press Release: Sanofi to acquire Vigil Neuroscience, Inc., adding a new investigational medicine to treat Alzheimer’s disease to the neurology pipeline
    Sanofi to acquire Vigil Neuroscience, Inc., adding a new investigational medicine to treat Alzheimer’s disease to the neurology pipeline Paris, May 22, 2025. Sanofi announced today ...
    06.05.25 - GlobeNewswire
    Capgemini confirms its ESG commitment with an updated policy and enhanced objectives
    Press contact: Sereydana Oum Tel.: +33 6 61 42 03 59 E-mail: sereydana.oum@capgemini.com
    06.05.25 - GlobeNewswire
    ArcelorMittal announces results of its General Meeting
    6 May 2025, 15.15 CET
    30.04.25 - GlobeNewswire
    Press Release: Annual General Meeting of April 30, 2025
    Annual General Meeting of April 30, 2025 Approval of the financial statements for the fiscal year 2024 Distribution of a cash dividend of €3.92 per share, with payment as of May 14, ...
    30.04.25 - EQS
    EQS-Adhoc: Airbus SE: Airbus reports First Quarter (Q1) 2025 results
    EQS-​Ad-hoc: Airbus SE / Key word(s): Quarter Results Airbus SE: Airbus reports First Quarter (Q1) 2025 results 30-Apr-2025 / 17:35 CET/CEST Disclosure of an inside information ...
    30.04.25 - GlobeNewswire
    Press Release: Sanofi and CD&R close Opella transaction, create global consumer healthcare leader
    Sanofi and CD&R close Opella transaction, creat e global consumer healthcare leader Paris, April 30, 2025 . Opella today becomes an independent global leader in consumer ...
    30.04.25 - GlobeNewswire
    ArcelorMittal S.A.: ArcelorMittal reports first quarter 2025
    Luxembourg, April 30 , 20 25 - ArcelorMittal (referred to as “ArcelorMittal” or the “Company” or the "Group") (MT (New York, Amsterdam, Paris, Luxembourg), MTS (Madrid)), the world’s ...

    Newssuche

    Videos

    newspaper
    20.06.25 +4,69%
    Technical Trading: Baumwolle Zukauf Chance
    Cotton Long Typ: Turbo Open End WKN: VP6N8D Hebel: 3,80 Laufzeit: OpenEnd Einstieg: Market ... Mehr »